- The UK is to offer alternatives to the AstraZeneca vaccine to under-30s over reports of blood clots.
- Officials say the “suspected” side effect is very rare, and vaccine benefits still outweigh risks.
- But they said the decision was made as young people face more risk of clots and less from COVID-19.
- The chart above, made by the UK Medicines and Healthcare products Regulatory Agency, shows this balance of risks.
- See more stories on Insider’s business page.
Get the latest coronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.
Source: Read Full Article
BPA-like chemical raising concern of ‘alarming’ brain damage: study
Fauci says Johnson & Johnson vaccine pause will last days, not months
Stones were carried 600 miles across the US in DINOSAUR bellies
Titanic conspiracy theories on tragedy’s anniversary from murder to mummy curse
Asteroid the size of a BUS passes just 12,000 miles from the Earth
NASA's InSight Mars lander is in emergency hibernation. If it can't save its batteries, it could die.
A remote British island is now 100% vaccinated after all 45 adult residents got their second dose
Alien abduction caught on video? Watch the bizarre moment man ‘shoots up’ into the sky